GDNF family receptor alpha-like (GFRAL) expression is restricted to the caudal brainstem.
Level 5 - mechanism / opinion, no new human data
Preclinical animal model study combined with secondary analysis of human transcriptomic data
PubMed 39608751 · doi:10.1016/j.molmet.2024.102070
What was done
Researchers mapped the expression profile of Gfral/GFRAL across central and peripheral tissues. In Gfral:eGFP reporter mice, 12 distinct tissues including brain regions were collected and analyzed for Gfral expression using single-molecule in situ hybridization (smFISH). Findings were compared against human tissue expression profiles analyzed from publicly available single-cell RNA sequencing (scRNA-seq) datasets.
What was found
In mice, Gfral mRNA was readily detected within the area postrema and nucleus of the solitary tract (AP/NTS) of the caudal brainstem, but not in other brain sites. In mouse peripheral tissues, Gfral-labelled cells were absent in the vast majority of examined tissues and extremely rare when present. Human scRNA-seq confirmed sparse GFRAL-expressing cells in some non-AP/NTS sites, but no non-brainstem tissue showed Gfral labelling consistently across all three detection methods (smFISH, genetic reporter, and scRNA-seq). The abstract reported no numerical counts or quantitative values.
Why it matters
Confirming the strict localization of GFRAL to the caudal brainstem clarifies the primary site of GDF15 action and suggests therapies targeting the GDF15-GFRAL axis (e.g., for cancer cachexia) act centrally rather than via peripheral GFRAL receptors.
Limits
Sample sizes for mice and human single-cell datasets were not specified in the abstract. Protein-level receptor abundance and functional signaling were not directly quantified across peripheral human organs.